Health ❯ Medicine

Immunotherapy

Cancer Immunotherapy Cancer Vaccines CAR T Cells CAR T-cell Therapy Stem Cell Therapy Immune Aging Cell Types Immune Response Improvement Cancer treatment T-Cells Aspirin Neoantigen therapy T Cell Therapy Combination Therapy Cancer Treatment Tumor Microenvironment Checkpoint Inhibitors Cancer Immunology Cytokines Extracellular Vesicles Autoimmune Diseases Natural Killer Cells Cell Therapy

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

The strategy tethers IL-12 to a PD-L1 blocker to concentrate immune activation at the tumor with minimal systemic toxicity.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.